Knowledge and Understanding of the Safety and Efficacy Aspects of BRIDION® Among Canadian Anesthesiologists

• Главные авторы: Annette Stemhagen (Автор), Parambir Bhangu (Автор), Wenjun Zhong (Автор), Michele Julian (Автор), Gretty Deutsch (Автор), Carol Koro (Автор)
• Формат: ‌
• Опубликовано: Adis, Springer Healthcare, 2020-05-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Background BRIDION® (sugammadex sodium) is an agent for the reversal of neuromuscular blockade (NMB) induced by rocuronium and vecuronium in general anesthesia. Following the approval of sugammadex in Canada (February 2016), Health Canada required a survey to assess the knowledge and unders...